Clinical Trial Update: Composition for Treating Cirrhosis and Liver Cancer (SB-1121) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update indicating completion of SB-1121 for cirrhosis of the liver.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis

Drugs mentioned

• SB-1121

Snippet

Sponsor: Nguyen Thi Trieu, MD | Conditions: Cirrhosis of the Liver | Phase 4 | Status: COMPLETED